 |
Since the establishment 42 years ago, CJ's biotechnology business has been giving efforts to develop products that fulfill everyone's
desire for health by increasing product groups with its biotechnology represented by the mass fermentation technology and the wide
variety of research in the pharmaceutical area.
CJ manufactured nucleic acids such as MSG (monosodium glutamate), IMP, GMP, and I&G starting with the production of condiments through
the fermentation technology it developed for the first time in Korea in 1963. Also, it is playing a pivotal role in CJ's globalization
through various activities such as the production of threonine and lysine, the growth promoter used with cattle feed in Indonesia, the
place of the raw materials are produced, the exportation to European and American regions, and the establishment of plants in the place
of raw material production. CJ is also giving much effort in strengthening R&D capacities such as it established a branch of Bio
Research Center in Daejeon, the Mecca of bio-engineering and technology, to support technological development.
CJ started the pharmaceutical business in 1984, and it established a strong footing in the field as the company with strong research
capabilities and potentials with the successful release of hepaccine, the vaccine for hepatitis-B. And now, it is growing into the
world's leader in the pharmaceutical industry contributing to the healthy life of the patients in and out of the country with the
continuous development of a variety of vaccines, cytokine, medicines for geriatric diseases, and antibiotics based on advanced
bioengineering technology including the latest recombinant DNA technology.
The recent acquisition of Hanil Pharm reflected CJ's strong will to strengthen its capabilities in the pharmaceutical business with and
gave CJ an opportunity to bring out the synergy in the sales and profit/loss areas and strengthen the overseas license network as Hanil
Pharm has many original licenses for excellent foreign medicines such as Mevalotin, Bana, Herben, and Selbex.
CJ has laying the foundation for the development of the new products by making full use of the technological strength through the latest
research facilities will continue to maintain its position as the leading company in the biotechnology and pharmaceutical areas in the
growing global market through the know-how and the competitive strength with the price so that the customers can enjoy 'healthy' life
and will lead the bio industry of the next generation by accelerating the development of environment-friendly biotechnical materials
such as the microbiological products and biodegradable products. |
|
|
